GlassScriptPhysician profile
Peter L Klemin
NPI 1124228630
$790.20
in general payments reported to CMS, 2019-2025
15 companies · $91.11 in 2025
The $91.11 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $104 · 2020: $242 · 2022: $36.10 · 2023: $123 · 2024: $194 · 2025: $91.11.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $408.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $407.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $282.77 | 2019-2025 | Veozah |
| Intuitive Surgical, INC. | $204.99 | 2020 | |
| Hologic Sales and Service, LLC | $52.18 | 2019-2025 | Thinprep 2000 Processor |
| Merck Sharp & Dohme LLC | $37.58 | 2019-2024 | Gardasil 9, Gardasil |
| Abbvie INC. | $29.51 | 2019-2020 | |
| Pfizer INC. | $29.13 | 2024 | |
| Smith+Nephew, INC. | $24.15 | 2020 | |
| Coloplast Corp | $21.04 | 2022 | |
| Boston Scientific Corporation | $18.15 | 2024 | Solyx Sis System |
| Axonics, INC. | $17.49 | 2023 | Axonics |
| Sumitomo Pharma America, INC. | $15.88 | 2023 | Myfembree |
| Daiichi Sankyo INC. | $15.06 | 2022 | |
| Sage Therapeutics, LLC | $14.94 | 2024 | |
| Organon LLC | $14.88 | 2023 | Nexplanon |
| Ethicon US, LLC | $12.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Klemin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.